Search
for
Sort by
Research 241–270 of 1000+
- Can nanozymes make the leap to the clinic? Advances, hurdles, and prospects
- Nanotechnology Approaches in Chronic Wound Healing
- Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing
- Silk Fibroin Nanofibers: Advancements in Bioactive Dressings through Electrospinning Technology for Diabetic Wound Healing
- Therapeutic Potential of Brassinosteroids in Biomedical and Clinical Research
- Silk fibroin–gelatin photo-crosslinked 3D-bioprinted hydrogel with MOF-methylene blue nanoparticles for infected wound healing
- Liposomes and Other Nanocarriers for the Treatment of Acne Vulgaris: Improved Therapeutic Efficacy and Skin Tolerability
- Current Biomedical Applications of 3D-Printed Hydrogels
- Biomembrane-Based Nanostructure- and Microstructure-Loaded Hydrogels for Promoting Chronic Wound Healing
- Cold Plasma An emerging technology for clinical use in wound healing
- Advanced polymer hydrogels that promote diabetic ulcer healing: mechanisms, classifications, and medical applications
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- Therapeutic Potential of Chitosan-Based and Related Nanocomposite Systems in Wound Management: A Review
- Barrett's esophagus as a premalignant condition; medical and surgical therapeutic management
- Serological Diagnosis of Helicobacter pylori Infection in Patients With a Polycystic Ovary Syndrome
- Drug-Loaded Extracellular Vesicle-Based Drug Delivery: Advances, Loading Strategies, Therapeutic Applications, and Clinical Challenges
- Senotherapeutic Potential of Araliadiol in Senescent Human Dermal Fibroblasts: An In Vitro Study Using Three Senescence Models
- Sexual Dysfunction in Polycystic Ovary Syndrome (PCOS): A Biopsychosocial Approach to Assessment and Management
- Black Hairy Tongue Syndrome: Case Report and Review of the Literature
- Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin.
- Cell-Type-Specific Chromatin States Differentially Prime Squamous Cell Carcinoma Tumor-Initiating Cells for Epithelial to Mesenchymal Transition
- Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environment
- Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice
- Overexpression of protein kinase C-α in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-α expression but not tumor promotion
- Genetic architecture of mouse skin inflammation and tumour susceptibility
- Tumor Angiogenesis and Anti-angiogenic Therapy
- Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion.
- Regulation of Mitochondrial Oxidative Metabolism by Tumor Suppressor FLCN
- Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice.
- Induction of dark keratinocytes by 12-O-tetradecanoyl-phorbol-13-acetate and mezerein as an indicator of tumor-promoting efficiency